ELYSIUM THERAPEUTICS
Elysium Therapeutics is a health care company that focuses on biotechnology, fitness, medical, and robotics. It was founded in 2013 and headquartered in Danville, California.
ELYSIUM THERAPEUTICS
Industry:
Biotechnology Fitness Health Care Medical Robotics
Founded:
2013-01-01
Address:
Danville, California, United States
Country:
United States
Website Url:
http://www.elysiumrx.com
Total Employee:
1+
Status:
Active
Contact:
(925) 399-7246
Total Funding:
1.58 M USD
Similar Organizations
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
Neurobotics Laboratory
At the Neurobotics Lab, They focus on creating bio- and neural-inspired robotic algorithms and systems.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Current Employees Featured
Founder
Investors List
Tech Coast Angels
Tech Coast Angels investment in Private Equity Round - Elysium Therapeutics
Mid Atlantic Bio Angels
Mid Atlantic Bio Angels investment in Venture Round - Elysium Therapeutics
Official Site Inspections
http://www.elysiumrx.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Elysium Therapeutics"
Elysium Therapeutics, Inc. | LinkedIn
Elysium Therapeutics, Inc. | 219 followers on LinkedIn. Reducing suffering from severe pain, opioid abuse and fatal overdose | Elysium’s mission is to reduce suffering from severe acute pain ...See details»
Elysium Therapeutics - Crunchbase Company Profile & Funding
Elysium Therapeutics is a health care company that focuses on biotechnology, fitness, medical, and robotics. It was founded in 2013 and headquartered in Danville, California.See details»
Elysium Therapeutics - Craft
Elysium Therapeutics is a company that develops and provides disruptive pain therapies. It offers O2P, a platform that provides self-limiting exposure to active opioids and prevents overdose; …See details»
Elysium Therapeutics, Inc. | Akron, OH, USA Startup
May 1, 2013 Website elysiumrx.com; Company Summary Attractive risk/reward profile: 1. High-probability of Success: Proof-of-concept support its NCEs comprised of FDA-approved drugs 2. Capital Efficiency: Leverage non-dilutive …See details»
Elysium Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Www.elysiumrx.com. Holding Company | 2013 | California, United States | < 10 | www.elysiumrx.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational …See details»
Elysium Therapeutics - Overview, News & Similar companies
Jul 23, 2024 Elysium Therapeutics to Present Phase 1 Proof-of-Concept Results for Novel SMARTâ„¢ O2P Opioid Technology at PAINWeek 2024 Phase 1 results demonstrated effective …See details»
Elysium Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Elysium Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Team — Elysium Therapeutics
Prior to co-founding Elysium in 2013, Dr. Jenkins co-founded Signature Therapeutics (Now Ensysce Biosciences), where he served as Chief Scientific Officer and led a highly productive …See details»
Elysium Therapeutics, Inc. Company Information - Funding, …
Get information on funding, investors, industries, and more for Elysium Therapeutics, Inc.. See Elysium Therapeutics, Inc. company profile and funding data.See details»
New Tools to Combat Prescription Opioid Abuse and Synthetic …
Greg Sturmer, Co-Founder and CEO of Elysium Therapeutics, a company with expertise in reducing pain and addressing opioid use disorder and fatal overdose from fentanyl. Elysium …See details»
Elysium Therapeutics, Inc. Overview | SignalHire Company Profile
Organization Website: elysiumrx.com : Phone Number (925) 399-7246: Elysium Therapeutics... industries Biotech: Headquarters Location: 1201 E Market St., Akron, OH, 44305 US 1201 E …See details»
Elysium Therapeutics to Present Phase 1 Proof-of-Concept Results …
Jul 23, 2024 Elysium Therapeutics, an emerging biopharmaceutical company establishing new standards for safety in the opioid industry by developing SMARTâ„¢ (Safer Medicines Alleviate …See details»
ELYSIUM THERAPEUTICS, INC. - VentureRadar
"Elysium’s mission is to disrupt the $10B+ prescription opioid pain medications market by accomplishing what others thought impossible – to create a new class of abuse deterrent …See details»
Press and Media — Elysium Therapeutics
In addition, Elysium is developing oral-overdose protected (O2Pâ„¢) hydrocodone for the treatment of moderate-to-severe acute pain. For more information, please visit …See details»
Elysium Therapeutics Announces Compelling Human Proof-of
Mar 5, 2024 Positive Phase 1 study results achieve a major milestone toward their mission to provide effective acute pain relief while simultaneously mitigating the major risks of existing …See details»
Elysium Therapeutics Announces Development of Overdose …
Apr 7, 2025 For more information, please visit https://www.elysiumrx.com. Contact. Tiberend Strategic Advisors, Inc. ... as the organization celebrates 20 years of transforming the …See details»
Elysium Therapeutics Presents Phase 1 Proof-of-Concept Results …
Sep 3, 2024 Elysium Therapeutics Presents Phase 1 Proof-of-Concept Results for Novel SMARTâ„¢ O2P Opioid Technology for Acute Pain that Reduces the Potential for Abuse, …See details»
Contact — Elysium Therapeutics
Contact us. Greg Sturmer, President and CEO . Lyons,CO [email protected] (925) 399-7246See details»
About — Elysium Therapeutics
Our Results. Our two flagship SMART product solutions, O2P (Oral Overdose Protected hydrocodone) and SOOPR (a long-acting rescue agent designed to be effective against …See details»
Elysium Therapeutics to Host Investor Webcast Highlighting …
2 days ago LYONS, Colo., May 12, 2025 /PRNewswire/ -- Elysium Therapeutics, an emerging biopharmaceutical company developing treatments specifically designed to rescue and …See details»